SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-15
👔
Nuvalent, Inc.
@NUVL_InsiderForm 4 Filing: Turner Christopher Durant Sells $3.9M of $NUVL
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Nuvalent, Inc.
Ticker: $NUVL
Transaction Value
$3.9M
Price/Share: $38.58
transaction date
2026-07-15
Shares: 101,330
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Turner Christopher Durant, holds the title of Chief Medical Officer at Nuvalent, Inc..
On 2026-07-15, the insider transacted 101,330 shares.The shares were transacted at a weighted average price of $38.58 per share, resulting in a total market-relevant value of $3.9M.
Executive Summary Summary
Turner Christopher Durant (Chief Medical Officer) transacted $3.9M of $NUVL
Post-Transaction Position: 0 shares
SEC Accession No: 0001193125-26-305073 (CIK: 1862146)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.